JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Concert Pharmaceuticals (CNCE) PT Lowered to $15 at JMP Securities, Following Clinical Update
-
Concert Pharmaceuticals to Present at The JMP Securities CNS Forum
-
Concert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Concert Pharma (CNCE) Prices 4.75M Share Common Offering at $9.92/Sh
-
Concert Pharmaceuticals Announces Pricing of Public Offering
-
Concert Pharmaceuticals (CNCE) PT Raised to $25 at JMP Securities
-
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
-
Concert Pharmaceuticals (CNCE) PT Lowered to $20 at JMP Securities
-
Concert Pharmaceuticals (CNCE) PT Raised to $26 at JMP Securities
-
Concert Pharmaceuticals to Report First Quarter 2018 Financial Results on May 3, 2018, and Present at Upcoming Investor Conferences
-
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
-
Concert Pharmaceuticals to Present at Several Upcoming Investor Conferences
-
Concert Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Concert Pharmaceuticals Announces Completion of Public Offering
-
Concert Pharma (CNCE) Prices 3.3M Common Stock Offering at $15.15/Share
-
Concert Pharmaceuticals Announces Pricing of Public Offering
-
Concert Pharma (CNCE) Plans Common Stock Offering
-
Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
JMP Securities Starts Concert Pharmaceuticals (CNCE) at Market Perform
-
Concert Pharmaceuticals (CNCE) IPO Jumps Higher
-
Concert Pharmaceuticals (CNCE) Files $74.75M IPO

